Drinking malt whisky may help prevent cancer, a scientific conference has been told. The medicinal properties of antioxidants in red wine are well known, but delegates at a biochemistry conference were told that whisky offered "even greater health benefits".
Dr Jim Swan said: "There has been much in the news about the health benefits of antioxidants in red wine. By contrast, very little has been said about malt whisky distillery science. "However, research has shown that there are even greater health benefits to people who drink single malt whiskies. Why? Single malt whiskies have more ellagic acid than red wine."
However, Dr Lesley Walker of Cancer Research UK, pointed out "Ellagic acid is a powerful antioxidant but there is an abundance of this acid in soft fruits and she suggests this as a much healthier way of increasing antioxidant intake." She was very concerned that whisky was being promoted as a cancer prevention agent without data to support the claim. "On the contrary, there is considerable data documenting the link between drinking excess alcohol and the increased risk of a number of cancers, particularly in smokers," she said.
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...